Liz Hockley

Articles by Liz Hockley

Americas

SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute

South Korean company eyes new business opportunities following Supreme Court ruling | Pfizer had claimed infringement of patent covering Prevenar 13 shot.   22 May 2025

Americas

Sanofi unit loses genetic disorder patent at EPO after trio of challenges

Boards of Appeal revokes Genzyme patent, handing win to Accord Healthcare | Teva and Hetero Labs also previously filed oppositions | Patent refers to Cerdelga, part of Sanofi’s Gaucher disease franchise.   20 May 2025

Americas

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity.   1 May 2025

Careers

Fenwick establishes new Boston office with trio of IP partners from Cooley

Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.   17 April 2025

Pharma

AstraZeneca unit faces class-action suit over alleged Soliris monopoly

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of more than $2 billion.   17 April 2025

Pharma

Fed Circ decides fate of Orange Book patent covering blockbuster J&J schizophrenia drug

Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering Invega Sustenna.   15 April 2025

Europe

EPO: Biotech innovation strong, while pharma trails behind

According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.   8 April 2025

Americas

Fed Circ ruling on Wuhan import ban shakes up economic prong analysis

Key ruling in favour of Kansas-based biotech on genetically engineered proteins from China | Court supports ITC position | Small market segments can be substantial enough for domestic industry requirement.   11 February 2025

Americas

Regeneron holds off copies of $6bn eye treatment

Federal Circuit upholds preliminary injunctions blocking highly similar versions of Eylea | Samsung Biopeis and Formycon failed to convince that the patent-in-suit was invalid.   4 February 2025

Americas

New national rankings recognise top US patent firms and lawyers

LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing identifies the go-to firms and individuals for prosecution, litigation and strategic work in the US.   4 February 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.